Compare ARRY & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARRY | INSP |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | 2018 |
| Metric | ARRY | INSP |
|---|---|---|
| Price | $7.97 | $42.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | $10.21 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 6.2M | 854.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.56 | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,284,141,000.00 | $82,050,000.00 |
| Revenue This Year | $15.72 | $8.02 |
| Revenue Next Year | $8.08 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 40.22 | ★ 62.18 |
| 52 Week Low | $5.39 | $38.91 |
| 52 Week High | $12.23 | $147.03 |
| Indicator | ARRY | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 48.53 |
| Support Level | $7.78 | $39.26 |
| Resistance Level | $8.17 | $44.75 |
| Average True Range (ATR) | 0.66 | 1.96 |
| MACD | -0.01 | 0.43 |
| Stochastic Oscillator | 41.35 | 63.44 |
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.